AAAAAA
Results:
1-19
|
Results: 19
Authors:
SHETYE J
RAGNHAMMAR P
LILJEFORS M
CHRISTENSSON B
FRODIN JE
BIBERFELD P
MELLSTEDT H
Citation: J. Shetye et al., IMMUNOPATHOLOGY OF METASTASES IN PATIENTS OF COLORECTAL-CARCINOMA TREATED WITH MONOCLONAL-ANTIBODY 17-1A AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Clinical cancer research, 4(8), 1998, pp. 1921-1929
Authors:
LILJEFORS M
FRODIN JE
SHETYE J
PORWIT A
RAGNHAMMAR P
SAMANCI A
WEGER A
MELLSTEDT H
Citation: M. Liljefors et al., EPITHELIAL-CELLS IN THE BONE-MARROW (BM) OF COLORECTAL-CARCINOMA (CRC) PATIENTS - A TOOL TO MONITOR IMMUNOTHERAPY, European journal of cancer, 33, 1997, pp. 386-386
Authors:
EDLER D
BLOMGREN H
ALLEGRA CJ
JOHNSTON PG
LAGERSTEDT U
MAGNUSSON I
RAGNHAMMAR P
Citation: D. Edler et al., IMMUNOHISTOCHEMICAL DETERMINATION OF THYMIDYLATE SYNTHASE IN COLORECTAL-CANCER - METHODOLOGICAL STUDIES, European journal of cancer, 33(13), 1997, pp. 2278-2281
Authors:
RAGNHAMMAR P
WADHWA M
Citation: P. Ragnhammar et M. Wadhwa, NEUTRALIZING ANTIBODIES TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN CARCINOMA PATIENTS FOLLOWING GM-CSF COMBINATION THERAPY, Medical oncology, 13(3), 1996, pp. 161-166
Authors:
RAGNHAMMAR P
Citation: P. Ragnhammar, ANTI-TUMORAL EFFECT OF GM-CSF WITH OR WITHOUT CYTOKINES AND MONOCLONAL-ANTIBODIES IN SOLID TUMORS, Medical oncology, 13(3), 1996, pp. 167-176
Authors:
FAGERBERG J
RAGNHAMMAR P
LILJEFORS M
HJELM AL
MELLSTEDT H
FRODIN JE
Citation: J. Fagerberg et al., HUMORAL ANTIIDIOTYPIC AND ANTI-ANTI-IDIOTYPIC IMMUNE-RESPONSE IN CANCER-PATIENTS TREATED WITH MONOCLONAL-ANTIBODY 17-1A, Cancer immunology and immunotherapy, 42(2), 1996, pp. 81-87
Authors:
BLOMGREN H
EDLER D
HALLSTROM M
RAGNHAMMAR P
Citation: H. Blomgren et al., DUAL EFFECTS OF FOLINIC ACID IN 5-FLUOROURACIL INDUCED KILLING OF HUMAN TUMOR-CELL LINES IN-VITRO, Anticancer research, 16(5A), 1996, pp. 2713-2717
Authors:
WADHWA M
BIRD C
FAGERBERG J
GAINESDAS R
RAGNHAMMAR P
MELLSTEDT H
THORPE R
Citation: M. Wadhwa et al., PRODUCTION OF NEUTRALIZING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ANTIBODIES IN CARCINOMA PATIENTS FOLLOWING GM-CSF COMBINATION THERAPY, Clinical and experimental immunology, 104(2), 1996, pp. 351-358
Authors:
RAGNHAMMAR P
BLOMGREN H
Citation: P. Ragnhammar et H. Blomgren, HOW TO OPTIMIZE THE EFFECT OF 5-FLUOROURACIL MODULATED THERAPY IN ADVANCED COLORECTAL-CANCER, Medical oncology, 12(3), 1995, pp. 187-201
Authors:
HJELM AL
RAGNHAMMAR P
FAGERBERG J
MAGNUSSON I
FRODIN JE
SVANSTROM R
SHETYE J
MELLSTEDT H
WERSALL JP
Citation: Al. Hjelm et al., SUBCUTANEOUS INTERLEUKIN-2 AND ALPHA-INTERFERON IN ADVANCE COLORECTAL-CARCINOMA - A PHASE-II STUDY, Cancer biotherapy, 10(1), 1995, pp. 5-12
Authors:
RAGNHAMMAR P
FRODIN JE
HJELM AL
FAGERBERG J
WERSALL P
LINDEMALM C
NILSSON B
FOX K
MAGNUSSON I
EWERTH S
THOR K
SECHER E
MELLSTEDT H
Citation: P. Ragnhammar et al., DIFFERENT DOSE REGIMENS OF THE MOUSE MONOCLONAL-ANTIBODY 17-1A FOR THERAPY OF PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA, International journal of oncology, 7(5), 1995, pp. 1049-1056
Authors:
RAGNHAMMAR P
BLOMGREN H
EDLER D
LUNDELL G
MAGNUSSON I
SONNENFELD T
Citation: P. Ragnhammar et al., DIFFERENT DOSE REGIMENS OF 5-FLUOROURACIL AND INTERFERON-ALPHA IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA, European journal of cancer, 31A(3), 1995, pp. 315-320
Authors:
RAGNHAMMAR P
FAGERBERG J
FRODIN JE
WERSALL P
HANSSON LO
MELLSTEDT H
Citation: P. Ragnhammar et al., GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR AUGMENTS THE INDUCTION OF ANTIBODIES, ESPECIALLY ANTIIDIOTYPIC ANTIBODIES, TO THERAPEUTIC MONOCLONAL-ANTIBODIES, Cancer immunology and immunotherapy, 40(6), 1995, pp. 367-375
Authors:
FAGERBERG J
HJELM AL
RAGNHAMMAR P
FRODIN JE
WIGZELL H
MELLSTEDT H
Citation: J. Fagerberg et al., TUMOR-REGRESSION IN MONOCLONAL ANTIBODY-TREATED PATIENTS CORRELATES WITH THE PRESENCE OF ANTI-IDIOTYPE-REACTIVE T-LYMPHOCYTES, Cancer research, 55(9), 1995, pp. 1824-1827
Authors:
RAGNHAMMAR P
FRODIN JE
TROTTA PP
MELLSTEDT H
Citation: P. Ragnhammar et al., CYTOTOXICITY OF WHITE BLOOD-CELLS ACTIVATED BY GRANULOCYTE-COLONY-STIMULATING FACTOR, GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR AND MACROPHAGE-COLONY-STIMULATING FACTOR AGAINST TUMOR-CELLS IN THE PRESENCE OF VARIOUS MONOCLONAL-ANTIBODIES/, Cancer immunology and immunotherapy, 39(4), 1994, pp. 254-262
Authors:
FAGERBERG J
FRODIN JE
RAGNHAMMAR P
STEINITZ M
WIGZELL H
MELLSTEDT H
Citation: J. Fagerberg et al., INDUCTION OF AN IMMUNE NETWORK CASCADE IN CANCER-PATIENTS TREATED WITH MONOCLONAL-ANTIBODIES (AB(1)) .2. IS INDUCTION OF ANTIIDIOTYPE REACTIVE T-CELLS (T-3) OF IMPORTANCE FOR TUMOR RESPONSE TO MAB THERAPY, Cancer immunology and immunotherapy, 38(3), 1994, pp. 149-159
Authors:
RAGNHAMMAR P
FRIESEN HJ
FRODIN JE
LEFVERT AK
HASSAN M
OSTERBORG A
MELLSTEDT H
Citation: P. Ragnhammar et al., INDUCTION OF ANTI-RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (ESCHERICHIA COLI-DERIVED) ANTIBODIES AND CLINICAL EFFECTS IN NONIMMUNOCOMPROMISED PATIENTS, Blood, 84(12), 1994, pp. 4078-4087
Authors:
WERSALL JP
MASUCCI G
HJELM AL
RAGNHAMMAR P
FAGERBERG J
FRODIN JE
MERK K
LINDEMALM C
ERICSON K
KALIN B
MELLSTEDT H
Citation: Jp. Wersall et al., LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 103-111
Authors:
RAGNHAMMAR P
MAGNUSSON I
MASUCCI G
MELLSTEDT H
Citation: P. Ragnhammar et al., THE THERAPEUTIC USE OF THE UNCONJUGATED MONOCLONAL-ANTIBODIES (MAB) 17-1A IN COMBINATION WITH GM-CSF IN THE TREATMENT OF COLORECTAL-CARCINOMA (CRC), Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 61-70
Risultati:
1-19
|